Samsung subsidiary NeuroLogica said it's collaborating with Massachusetts General Hospital (MGH) to pilot the firm's OmniTom Elite scanner with photon-counting detector (PCD) CT technology at the point of care.
The company's OmniTom Elite CT scanner can now be upgraded with photon-counting detector technology, enabling multienergy CT to be utilized in point-of-care imaging applications, according to NeuroLogica. Once U.S. Food and Drug Administration (FDA) 510(k) clearance has been obtained for OmniTom Elite with PCD, MGH will assess the technology for monitoring post-trauma and postsurgical patients in the intensive care unit, NeuroLogica said.
The institution will also guide best practices and evaluate use cases for the system.
